Product Information
ATAZANAVIR SULFATE 300 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $2.5602 per EA under NDC 31722065530. Its NADAC has been published 185 times since Oct 19, 2022.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722065530
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATAZANAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212278On Market Since
2/7/2022
Pharmacological Classes
Price Statistics
The NADAC for ATAZANAVIR SULFATE 300 MG CAP has been published 185 times since Oct 19, 2022, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5602 per EA |
|---|---|
| All-time high | $3.4956 (Feb 15, 2023) |
| All-time low | $1.7959 (Aug 21, 2024) |
| 52-week high | $3.4622 |
| 52-week low | $2.5602 |
| Median price | $3.3149 |
| Average price | $3.0563 |
| Largest weekly change | +41.4% (Oct 23, 2024) |
| Weeks tracked | 185 |
| Tracking since | Oct 19, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATAZANAVIR SULFATE 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ATAZANAVIR SULFATE 300 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $2.5602 per EA (NDC 31722065530), effective Jun 24, 2026.
How has the price of ATAZANAVIR SULFATE 300 MG CAP changed over time?
Over the history we have for it, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has declined 26.8%. It has been tracked across 185 weekly CMS publications since Oct 19, 2022.
What are the highest and lowest recorded NADAC prices for ATAZANAVIR SULFATE 300 MG CAP?
Since Oct 19, 2022, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has ranged from a low of $1.7959 (Aug 21, 2024) to a high of $3.4956 (Feb 15, 2023), with a median of $3.3149 per EA.
Are there cheaper alternatives to ATAZANAVIR SULFATE 300 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ATAZANAVIR SULFATE 300 MG CAP, but none are currently priced below it.
Who manufactures ATAZANAVIR SULFATE 300 MG CAP?
ATAZANAVIR SULFATE 300 MG CAP (NDC 31722065530) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification